EagleClaw Capital Management’s Amgen AMGN Stock Holding History

EagleClaw Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$739K	Sell	2,100 -25	-1%	-$8.91K	0.1%	103
2025 Q4	$696K	Hold	2,125	–	–	0.1%	102
2025 Q3	$600K	Hold	2,125	–	–	0.08%	109
2025 Q2	$593K	Hold	2,125	–	–	0.09%	102
2025 Q1	$662K	Buy	2,125 +800	+60%	+$236K	0.1%	99
2024 Q4	$345K	Hold	1,325	–	–	0.05%	115
2024 Q3	$427K	Sell	1,325 -100	-7%	-$32.7K	0.07%	107
2024 Q2	$445K	Hold	1,425	–	–	0.08%	105
2024 Q1	$405K	Hold	1,425	–	–	0.07%	107
2023 Q4	$410K	Hold	1,425	–	–	0.09%	107
2023 Q3	$383K	Hold	1,425	–	–	0.09%	106
2023 Q2	$316K	Hold	1,425	–	–	0.07%	109
2023 Q1	$344K	Buy	1,425 +300	+27%	+$73.6K	0.08%	107
2022 Q4	$295K	Hold	1,125	–	–	0.07%	113
2022 Q3	$254K	Hold	1,125	–	–	0.07%	118
2022 Q2	$274K	Sell	1,125 -50	-4%	-$12.3K	0.07%	115
2022 Q1	$284K	Hold	1,175	–	–	0.07%	120
2021 Q4	$264K	Hold	1,175	–	–	0.06%	123
2021 Q3	$249K	Hold	1,175	–	–	0.06%	120
2021 Q2	$286K	Sell	1,175 -125	-10%	-$30.8K	0.07%	121
2021 Q1	$323K	Sell	1,300 -16	-1%	-$3.82K	0.09%	110
2020 Q4	$302K	Hold	1,316	–	–	0.1%	109
2020 Q3	$334K	Hold	1,316	–	–	0.12%	103
2020 Q2	$311K	Hold	1,316	–	–	0.12%	103
2020 Q1	$266K	Sell	1,316 -18	-1%	-$3.93K	0.13%	103
2019 Q4	$321K	Hold	1,334	–	–	0.12%	107
2019 Q3	$258K	Hold	1,334	–	–	0.11%	116
2019 Q2	$245K	Hold	1,334	–	–	0.11%	110
2019 Q1	$252K	Sell	1,334 -50	-4%	-$9.55K	0.12%	107
2018 Q4	$269K	Buy	1,384 +34	+3%	+$6.63K	0.14%	103
2018 Q3	$281K	Hold	1,350	–	–	0.12%	104
2018 Q2	$249K	Hold	1,350	–	–	0.12%	103
2018 Q1	$230K	Hold	1,350	–	–	0.12%	103
2017 Q4	$235K	Hold	1,350	–	–	0.12%	107
2017 Q3	$251K	Hold	1,350	–	–	0.14%	99
2017 Q2	$232K	Hold	1,350	–	–	0.14%	104
2017 Q1	$221K	Buy	+1,350	New	+$224K	0.13%	103
2016 Q4	–	Sell	-1,350	Closed	-$224K	–	106
2016 Q3	$224K	Hold	1,350	–	–	0.14%	100
2016 Q2	$205K	Hold	1,350	–	–	0.14%	103
2016 Q1	$202K	Hold	1,350	–	–	0.14%	101
2015 Q4	$219K	Buy	+1,350	New	+$212K	0.15%	97
2015 Q3	–	Sell	-1,350	Closed	-$208K	–	101
2015 Q2	$208K	Hold	1,350	–	–	0.13%	100
2015 Q1	$216K	Hold	1,350	–	–	0.14%	100
2014 Q4	$216K	Buy	+1,350	New	+$210K	0.14%	100

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

EagleClaw Capital Management's AMGN Position: Q1 2026 in Review

EagleClaw Capital Management reduced its Amgen (AMGN) stake by 1.2% in Q1 2026, selling an estimated $8.91K and leaving 2,100 shares worth $739K. The position accounts for 0.1% of the portfolio, ranked #103.

EagleClaw Capital Management first reported a position in AMGN in Q4 2014 and has held it in 44 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

EagleClaw Capital Management held 2,100 shares of Amgen worth $739K as of Q1 2026.
EagleClaw Capital Management sold 25 Amgen shares in Q1 2026, an estimated $8.91K.
Amgen made up 0.1% of EagleClaw Capital Management's portfolio in Q1 2026, its #103 holding.
EagleClaw Capital Management first reported a position in Amgen in Q4 2014 and has held it in 44 quarters since.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on EagleClaw Capital Management's 13F filing for Q1 2026, filed 8 May 2026.